N/A Completed N=159 Randomized Triple-blind Prevention

Tegaderm vs. EyeGard for Eye Protection

Erythema

Source: ClinicalTrials.gov NCT03549429 ↗

Enrolled (actual)

159

Serious AEs

0.0%

Results posted

Aug 2019

Primary outcomePrimary: Proportion of Participants With Eyelid Erythema — 117; 105 Participants — p=0.03

Summary

This study compares TegadermTM and EyeGard® in general anesthesia.

Outcome Measures

Outcome	Result	p-value
PRIMARY Proportion of Participants With Eyelid Erythema	117; 105	0.03 sig
SECONDARY Patient Satisfaction	4.94; 4.91	0.23
SECONDARY Rate of Corneal Abrasions	0; 0	—

Eligibility Criteria

Inclusion Criteria

Age ≥ 18
Surgeries scheduled for anesthesia of any duration

Exclusion Criteria

Any patient that does not consent
Any patient who has:
Pre-existing eyelid erythema or other eyelid trauma
Eyelid piercings
Any surgery on the head, brain, neck, teeth, mouth, eyes or face
Surgery in the prone position
Patients <18 years old

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03549429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.